SavedAdd your journal

Journals / Androloji Bülteni / 2017 / Cilt: 19 - Sayı: 1

The importance of testosterone in treatment of sexual dysfunction in postmenopausal women: a review of literature

Postmenopozal kadınlarda testosteron hormonunun cinsel disfonksiyon tedavisindeki önemi: literatürün gözden geçirilmesi

Cem YÜCEL
Mehmet Zeynel KESKİN
Özgür ÇAKMAK
Zafer KOZACIOĞLU
Pages
25–28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the importance of postmenopausal use of testosterone hormone in sexual dysfunction treatment has been discussed with the guide of current literature

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Female sexual dysfunction is a problem associated with many causes affecting 38–63% of women.
📊
Key Findings & Data:Testosterone and estrogen levels decrease in the postmenopausal period.
💡
Conclusion & Impact:In this review, the importance of postmenopausal use of testosterone hormone in sexual dysfunction treatment has been discussed with the guide of current literature
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Female sexual dysfunction is a problem associated with many causes affecting 38–63% of women. Alteration of hormonal balance with menopause causes female sexual dysfunction. Testosterone and estrogen levels decrease in the postmenopausal period. Menopause-induced androgen insufficiency may lead to chronic fatigue, depression, decreased libido and sexual dysfunction independent of estrogen deprivation. Many studies have reported that use of testosterone in postmenopausal women positively affects sexual desire, sexual arousal, vaginal blood flow, orgasm frequency and sexual satisfaction. The current data shows that androgens play an important role in female sexual functions. It is shown that transdermal testosterone may be effective in the treatment of postmenopausal women with sexual dysfunction. Currently, no hormone preparation such as testosterone or estrogen-testosterone has been approved in the treatment of postmenopausal sexual dysfunction. In this review, the importance of postmenopausal use of testosterone hormone in sexual dysfunction treatment has been discussed with the guide of current literature

Özet

Kadın cinsel disfonksiyonu, kadınların %38-63'ünü etkileyen birçok sebebe bağlı bir problemdir. Menopozla birlikte hormonal dengenin değişmesi, kadının cinsel disfonksiyonunu arttırır. Postmenopozal dönemde östrojen ile birlikte testosteron da azalır. Menopozla ortaya çıkan androjen yetersizliği, östrojen azalmasından bağımsız olarak, kronik yorgunluk, depresyon, libido azalması ve cinsel disfonksiyona yol açar. Günümüze kadar yapılmış birçok çalışma, postmenopozal kadınlarda testosteron kullanımının, östrojen terapisinden bağımsız olarak, cinsel istek, cinsel uyarılma, vajinal kan akımı, orgazm sıklığı ve cinsel tatmini olumlu yönde etkilediğini göstermiştir. Mevcut bilgiler androjenlerin kadın cinsel fonksiyonlarında önemli rol oynadığını göstermektedir. Cinsel disfonksiyonu olan postmenopozal kadınlarda transdermal testosteronun tedavide etkili olabileceği gösterilmiştir. Hâlen postmenopozal cinsel disfonksiyon semptomlarının tedavisinin testosteron veya östrojen-testosteron kombinasyonu şeklinde bir hormon preparatı kullanımı için onay alınmamıştır. Testosteron kullanımının etkinliğini ve güvenilirliğini ortaya koyacak uzun süreli çalışmalara gereksinim vardır Bu derlemede testosteron hormonunun postmenopozal kullanımının cinsel disfonksiyon tedavisindeki önemi literatür eşliğinde tartışılmıştır

🔖

Cite This Article

YÜCEL, C., KESKİN, M. Z., ÇAKMAK, Ö., KOZACIOĞLU, Z. (2017). The importance of testosterone in treatment of sexual dysfunction in postmenopausal women: a review of literature. Androloji Bülteni, Cilt: 19 - Sayı: 1, 25–28. https://ajindex.com/articles/147573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. KAYNAKLAR 1. Butler PA. Sexual health –a new focus for the WHO. Progress in Reproductive Health Research 2004
  2. 1–8. 2. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, et al. Report of the international consensus developmentconference on female sexual dysfunction: definitions and classifications. J Urol 2000
  3. 888–93. 3. Bayram GO, Şahin NO. Histerectomy’s psychosexual effects in turkish women. Sex Disabil 2008
  4. 149–58. 4. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005
  5. 3847–53. doi: 10.1210/jc.2005-0212 5. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sufate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000
  6. 2832–8. doi: 10.1210/jcem.85.8.6740 6. Zumof B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma estosteron concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995
  7. 1429– 30. doi: 10.1210/jcem.80.4.7714119 7. Haring R, Hannemann A, John U, Radke D, Nauck M, Wallaschofski H, et al. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatographytandem mass spectrometry. J Clin Endocrinol Metab 2012
  8. 408–15. doi: 10.1210/jc.2011- 2134 8. Pugeat M, Nader N, Hogeveen K, Raverot G, Déchaud H, Grenot C. Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol Cell Endocrinol 2010
  9. 53–9. doi: 10.1016/j.mce.2009.09.020 9. Zhuo FL, Xu W, Wang L, Wu Y, Xu ZL, Zhao JY. Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a metaanalysis. Clin Exp Dermatol 2012
  10. 104–11. doi: 10.1111/j.1365-2230.2011.04186.x 10. Wang F, Pan J, Liu Y, Meng Q, Lv P, Qu F, et al. Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci 2015
  11. 4743–8. doi: 10.1073/pnas.1418216112 11. Topic B, Tavares MC, Tomaz C, Mattern C. Prolonged effects of intra-nasally administered testosterone on proceptive behavior in female capuchin monkeys (Cebus apella). Behav Brain Res 2007
  12. 60–8. doi: 10.1016/j.bbr.2007.01.011 12. Tavares MC, Topic B, Abreu C, Waga I, Gomes U, Tomaz C, et al. Effects of intra-nasally administered testosterone on proceptive behavior in female capuchin monkeys (Cebus apell